Skip to main content
. 2017 Jul 19;8(43):74276–74286. doi: 10.18632/oncotarget.19395

Figure 1. The expression of miR-146a was upregulated in OS tissues and associated with tumor recurrence.

Figure 1

(A) The expression of miR-146a in 237 OS patient samples and 25 normal tissues shown by a 2015 TCGA data set. (B) TCGA data analysis of the expression of miR-146a in paired OS tissues (n=25). (C) The expression level of miR-146a in OS patients with tumor size≥8cm (n-74) and tumor size<8cm (n=119). (D) The cutoff value of miR-146a was determined by the patient survival time, status and miR-146 expression level. (E) The correlation of miR-146a high expression or low expression with the overall survival rate of OS patients. (F) The correlation of miR-146a high expression or low expression with the tumor recurrence rate of OS patients.